Jerry Ingram

Articles

Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.

R-CHOP is standard of care for advanced DLBCL patients

For clinicians, MRI may offer a more in-depth view than mammography for planning surgery and screening for contralateral breast cancers, but does use of MRI actually benefit patients?

Author | Jerry Ingram

Articles

New content coming soon, please check back later.